Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig00301 |
methionyl aminopeptidase 2 |
1145 |
20 |
5.51E-44 |
97.20% |
8 |
P:cobalt ion transport; F:cobalt ion transmembrane transporter activity; F:cobalt ion binding; P:Wnt receptor signaling pathway; F:methionyl aminopeptidase activity; F:protein binding; P:proteolysis; F:endopeptidase inhibitor activity |
EC:3.4.11.18 |
|
contig00302 |
---NA--- |
220 |
0 |
|
|
0 |
|
|
|
contig00303 |
mgc89011 protein |
398 |
20 |
1.21E-31 |
53.05% |
3 |
F:protein kinase activity; F:ATP binding; P:apoptosis |
|
|
contig00304 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig00305 |
---NA--- |
345 |
0 |
|
|
0 |
|
|
|
contig00306 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig00307 |
novel protein |
1633 |
20 |
3.57E-125 |
65.15% |
0 |
|
|
|
contig00308 |
sec13-like partial |
282 |
20 |
1.39E-24 |
83.25% |
6 |
C:cytoplasm; C:nuclear pore; P:intracellular protein transmembrane transport; P:mRNA transport; F:calcium ion binding; P:cytoskeleton organization |
|
|
contig00309 |
phd finger protein 5a |
478 |
20 |
1.06E-56 |
97.55% |
6 |
C:nucleolus; C:U2 snRNP; P:positive regulation of transcription, DNA-dependent; C:nuclear matrix; F:transcription factor activity; P:nuclear mRNA splicing, via spliceosome |
|
|
contig00310 |
thioredoxin reductase 3 |
249 |
20 |
4.32E-34 |
88.65% |
16 |
P:spermatogenesis; C:microsome; P:cell differentiation; ; F:thioredoxin-disulfide reductase activity; F:NADP or NADPH binding; F:selenium binding; P:cell redox homeostasis; P:multicellular organismal development; P:glutathione metabolic process; P:electron transport; P:transport; F:FAD binding; C:nucleus; F:protein disulfide oxidoreductase activity; C:endoplasmic reticulum |
EC:1.6.4.0; EC:1.8.1.9 |
|
contig00311 |
biphenyl hydrolase-like (serine breast epithelial mucin-associated antigen) |
483 |
20 |
3.39E-42 |
80.65% |
1 |
F:hydrolase activity |
|
|
contig00312 |
---NA--- |
1914 |
0 |
|
|
0 |
|
|
|
contig00313 |
---NA--- |
363 |
0 |
|
|
0 |
|
|
|
contig00314 |
timeless interacting protein |
279 |
20 |
6.48E-22 |
82.65% |
10 |
P:regulation of DNA replication during S phase; C:nuclear chromatin; P:DNA replication checkpoint; P:cell division; P:replication fork protection; P:intra-S DNA damage checkpoint; F:protein binding; P:mitosis; P:positive regulation of cell proliferation; C:cytoplasm |
|
|
contig00315 |
atp-binding sub-family f member 2 |
1925 |
20 |
0 |
90.70% |
5 |
F:ATPase activity, coupled to transmembrane movement of substances; C:mitochondrial envelope; P:transport; F:ATP binding; C:ATP-binding cassette (ABC) transporter complex |
|
|
contig00316 |
egg envelope component zpc |
1402 |
20 |
3.60E-83 |
46.40% |
1 |
C:viral envelope |
|
|
contig00317 |
---NA--- |
295 |
0 |
|
|
0 |
|
|
|
contig00318 |
mhc class i antigen |
259 |
20 |
9.93E-18 |
68.75% |
5 |
F:receptor activity; C:membrane; P:antigen processing and presentation; C:MHC class I protein complex; P:immune response |
|
|
contig00319 |
set domain-containing protein 8 |
1458 |
20 |
8.49E-83 |
81.55% |
9 |
P:chromatin modification; P:regulation of transcription, DNA-dependent; F:histone-lysine N-methyltransferase activity; P:cell division; F:protein binding; P:mitosis; P:transcription antitermination; C:chromosome; C:nucleus |
EC:2.1.1.43 |
|
contig00320 |
---NA--- |
470 |
0 |
|
|
0 |
|
|
|
contig00321 |
---NA--- |
1632 |
0 |
|
|
0 |
|
|
|
contig00322 |
myosin light chain kinase |
2452 |
20 |
0 |
62.30% |
2 |
F:binding; F:kinase activity |
|
|
contig00323 |
tetratricopeptide repeat domain 9c |
1112 |
20 |
1.21E-80 |
67.05% |
1 |
P:protein folding |
|
|
contig00324 |
---NA--- |
302 |
0 |
|
|
0 |
|
|
|
contig00325 |
qil1 |
870 |
20 |
4.51E-39 |
72.65% |
1 |
F:protein binding |
|
|
contig00326 |
acyl carrier mitochondrial precursor |
724 |
20 |
1.93E-68 |
75.75% |
8 |
P:fatty acid biosynthetic process; F:NADH dehydrogenase (ubiquinone) activity; F:calcium ion binding; C:mitochondrial respiratory chain complex I; F:acyl carrier activity; P:mitochondrial electron transport, NADH to ubiquinone; C:mitochondrial matrix; F:fatty acid binding |
EC:1.6.5.3 |
|
contig00327 |
translocase of outer mitochondrial membrane 34 |
305 |
20 |
1.55E-23 |
81.25% |
3 |
F:protein binding; C:mitochondrion; C:membrane |
|
|
contig00328 |
translocation associated membrane protein 1 |
578 |
20 |
5.52E-87 |
87.20% |
5 |
P:intracellular protein transmembrane transport; F:receptor activity; C:endoplasmic reticulum membrane; C:membrane attack complex; P:cotranslational protein targeting to membrane |
|
|
contig00329 |
---NA--- |
105 |
0 |
|
|
0 |
|
|
|
contig00330 |
---NA--- |
328 |
0 |
|
|
0 |
|
|
|
contig00331 |
spindle pole body component 25 |
342 |
20 |
7.36E-29 |
65.55% |
1 |
P:cellular process |
|
|
contig00332 |
heterogeneous nuclear ribonucleoprotein a0 |
644 |
20 |
6.28E-91 |
87.40% |
3 |
F:nucleic acid binding; F:nucleotide binding; C:ribonucleoprotein complex |
|
|
contig00333 |
transcription initiation factor tfiid subunit 9 |
689 |
20 |
1.94E-59 |
87.70% |
9 |
F:adenylate kinase activity; P:transcription initiation; P:regulation of transcription, DNA-dependent; F:protein C-terminus binding; F:DNA binding; F:ATP binding; F:transcription coactivator activity; C:transcription factor TFIID complex; P:transcription from RNA polymerase II promoter |
EC:2.7.4.3 |
|
contig00334 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig00335 |
---NA--- |
354 |
0 |
|
|
0 |
|
|
|
contig00336 |
---NA--- |
280 |
0 |
|
|
0 |
|
|
|
contig00337 |
---NA--- |
314 |
0 |
|
|
0 |
|
|
|
contig00338 |
transmembrane protein 49 |
882 |
20 |
4.48E-117 |
90.65% |
4 |
C:membrane attack complex; C:endoplasmic reticulum; C:ER-Golgi intermediate compartment; C:Golgi apparatus |
|
|
contig00339 |
exosome component 2 |
597 |
20 |
8.74E-62 |
93.90% |
7 |
C:cytoplasm; F:3'-5'-exoribonuclease activity; F:protein binding; P:rRNA processing; C:exosome (RNase complex); C:nucleus; F:7S RNA binding |
|
|
contig00340 |
overexpressed breast tumor protein homolog |
801 |
20 |
1.21E-24 |
89.55% |
0 |
|
|
|
contig00341 |
thap domain containing 4 |
809 |
20 |
3.42E-67 |
83.50% |
2 |
F:zinc ion binding; F:DNA binding |
|
|
contig00342 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
contig00343 |
eukaryotic translation initiation factor subunit e |
1451 |
20 |
0 |
97.05% |
6 |
F:translation initiation factor activity; P:camera-type eye development; C:eukaryotic translation initiation factor 3 complex; F:protein binding; P:regulation of translational initiation; P:embryonic viscerocranium morphogenesis |
|
|
contig00344 |
coilin |
571 |
20 |
1.44E-15 |
75.25% |
5 |
F:protein C-terminus binding; C:nucleolus; C:Cajal body; F:disulfide oxidoreductase activity; C:female germ cell nucleus |
|
|
contig00345 |
kiaa0776 protein |
243 |
20 |
2.55E-34 |
92.25% |
1 |
F:protein binding |
|
|
contig00346 |
leucine-rich ppr-motif containing |
1162 |
20 |
9.82E-89 |
60.30% |
9 |
P:cellular process; P:transport; C:cytoskeleton; C:mitochondrion; C:condensed nuclear chromosome; F:actin filament binding; C:perinuclear region of cytoplasm; F:single-stranded DNA binding; F:beta-tubulin binding |
|
|
contig00347 |
aldo-keto reductase family member a1 (aldehyde reductase) |
986 |
20 |
2.36E-122 |
87.65% |
11 |
P:D-glucuronate catabolic process; P:aldehyde catabolic process; C:apical plasma membrane; F:electron carrier activity; F:protein binding; F:alcohol dehydrogenase (NADP+) activity; P:glucose metabolic process; P:L-ascorbic acid biosynthetic process; F:L-glucuronate reductase activity; F:aldehyde reductase activity; C:cytosol |
EC:1.1.1.2; EC:1.1.1.19; EC:1.1.1.21 |
|
contig00348 |
programmed cell death 4 |
1109 |
20 |
1.07E-28 |
88.95% |
6 |
P:apoptosis; F:RNA binding; C:cytoplasm; P:negative regulation of cell cycle; C:nucleus; F:protein binding |
|
|
contig00349 |
peroxisomal -enoyl- isomerase |
2042 |
20 |
1.07E-161 |
79.50% |
4 |
C:peroxisome; F:acyl-CoA binding; P:fatty acid metabolic process; F:isomerase activity |
|
|
contig00350 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
contig00351 |
cu051 protein |
1099 |
5 |
6.87E-12 |
87.80% |
0 |
|
|
|
contig00352 |
---NA--- |
296 |
0 |
|
|
0 |
|
|
|
contig00353 |
---NA--- |
525 |
0 |
|
|
0 |
|
|
|
contig00354 |
uracil-dna glycosylase |
1272 |
20 |
3.66E-140 |
81.45% |
9 |
P:somatic hypermutation of immunoglobulin genes; C:mitochondrion; F:uracil DNA N-glycosylase activity; P:somatic recombination of immunoglobulin gene segments; P:base-excision repair; F:protein binding; P:negative regulation of apoptosis; C:nucleus; F:uridine nucleosidase activity |
EC:3.2.2.3 |
|
contig00355 |
tia1 cytotoxic granule-associated rna binding protein |
484 |
20 |
8.03E-60 |
85.70% |
8 |
P:negative regulation of cytokine biosynthetic process; P:negative regulation of translation; P:induction of apoptosis; F:poly(A) RNA binding; F:AU-rich element binding; F:nucleotide binding; C:cytoplasm; C:nucleus |
|
|
contig00356 |
chromosome 20 open reading frame 149 |
595 |
11 |
3.10E-19 |
61.64% |
0 |
|
|
|
contig00357 |
rna pseudouridylate synthase domain containing 4 |
523 |
20 |
1.78E-37 |
78.15% |
3 |
F:RNA binding; P:pseudouridine synthesis; F:pseudouridine synthase activity |
EC:5.4.99.12 |
|
contig00358 |
importin 7 |
894 |
20 |
3.93E-110 |
89.10% |
5 |
C:cytoplasm; C:nuclear pore; P:protein import into nucleus, docking; F:histone binding; F:protein transporter activity |
|
|
contig00359 |
tetraspanin 13 |
781 |
20 |
1.00E-76 |
81.10% |
3 |
C:membrane attack complex; C:membrane fraction; C:integral to plasma membrane |
|
|
contig00360 |
---NA--- |
819 |
0 |
|
|
0 |
|
|
|
contig00361 |
dead (asp-glu-ala-asp) box polypeptide y-linked |
434 |
20 |
4.60E-76 |
95.80% |
6 |
F:RNA binding; F:ATP binding; C:cytoplasm; C:nucleus; F:DNA binding; F:ATP-dependent helicase activity |
|
|
contig00362 |
loc100003370 protein |
568 |
2 |
3.16E-07 |
46.00% |
0 |
|
|
|
contig00363 |
ribosomal protein s17 |
245 |
20 |
5.49E-37 |
98.10% |
4 |
F:structural constituent of ribosome; F:RNA binding; C:cytosolic small ribosomal subunit; P:translation |
EC:3.6.5.3 |
|
contig00364 |
thump domain containing 1 |
534 |
20 |
7.84E-68 |
79.65% |
3 |
F:F; P:P; C:C |
|
|
contig00365 |
---NA--- |
559 |
0 |
|
|
0 |
|
|
|
contig00366 |
---NA--- |
272 |
0 |
|
|
0 |
|
|
|
contig00367 |
proteasome ( macropain) 26s non- 13 |
1503 |
20 |
0 |
91.40% |
5 |
C:cytosol; P:meiosis I; C:proteasome regulatory particle; F:protein binding; F:endopeptidase activity |
|
|
contig00368 |
---NA--- |
945 |
0 |
|
|
0 |
|
|
|
contig00369 |
ubinuclein 2 |
214 |
20 |
5.69E-10 |
67.50% |
0 |
|
|
|
contig00370 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
contig00371 |
map kinase-interacting serine threonine kinase 2 |
707 |
20 |
1.00E-120 |
93.45% |
9 |
P:protein amino acid phosphorylation; P:intracellular protein kinase cascade; F:protein binding; F:ATP binding; F:magnesium ion binding; P:regulation of translation; F:zinc ion binding; P:cell surface receptor linked signaling pathway; F:protein serine/threonine kinase activity |
EC:2.7.11.0 |
|
contig00372 |
---NA--- |
696 |
0 |
|
|
0 |
|
|
|
contig00373 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
contig00374 |
---NA--- |
213 |
0 |
|
|
0 |
|
|
|
contig00375 |
dihydrofolate reductase |
711 |
20 |
9.01E-39 |
76.05% |
7 |
F:dihydrofolate reductase activity; P:dihydrofolate metabolic process; P:response to nicotine; P:heart contraction; P:heart morphogenesis; P:tetrahydrofolate biosynthetic process; P:primary metabolic process |
EC:1.5.1.3 |
|
contig00376 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig00377 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig00378 |
---NA--- |
229 |
0 |
|
|
0 |
|
|
|
contig00379 |
---NA--- |
120 |
0 |
|
|
0 |
|
|
|
contig00380 |
---NA--- |
778 |
0 |
|
|
0 |
|
|
|
contig00381 |
sphingomyelin phosphodiesterase acid lysosomal |
3206 |
20 |
0 |
73.20% |
10 |
C:lamellar body; P:response to cocaine; P:positive regulation of apoptosis; F:integrase activity; C:extracellular space; F:sphingomyelin phosphodiesterase activity; P:nervous system development; P:signal transduction; P:ceramide biosynthetic process; P:response to drug |
EC:3.1.4.12 |
|
contig00382 |
glutamate-rich wd repeat containing 1 |
252 |
20 |
1.21E-39 |
82.75% |
1 |
C:nucleus |
|
|
contig00383 |
phosphohistidine phosphatase 1 |
416 |
20 |
1.07E-32 |
80.70% |
1 |
F:hydrolase activity |
|
|
contig00384 |
---NA--- |
497 |
0 |
|
|
0 |
|
|
|
contig00385 |
nucleoporin 54kda |
248 |
20 |
2.22E-38 |
95.30% |
5 |
C:cytoplasm; C:nuclear pore; P:intracellular protein transmembrane transport; C:nucleoplasm; P:mRNA transport |
|
|
contig00386 |
guanine nucleotide binding protein (g protein) beta polypeptide 2-like 1 |
1078 |
20 |
3.00E-121 |
98.35% |
10 |
C:cytoplasm; F:receptor activity; P:protein localization; C:neuronal cell body; C:heterotrimeric G-protein complex; F:kinase activity; P:activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway; F:receptor binding; F:protein kinase C binding; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig00387 |
plexin domain containing 2 |
377 |
20 |
1.12E-53 |
87.75% |
5 |
C:integral to membrane; C:extracellular space; P:multicellular organismal development; F:receptor activity; C:plasma membrane |
|
|
contig00388 |
minichromosome maintenance complex component 2 |
2355 |
20 |
0 |
93.50% |
15 |
P:regulation of DNA replication initiation; F:zinc ion binding; P:cell cycle; C:nuclear origin of replication recognition complex; P:regulation of transcription, DNA-dependent; P:DNA unwinding involved in replication; C:MCM complex; F:ATP binding; F:DNA replication origin binding; C:chromatin; F:protein binding; P:nucleosome assembly; F:DNA-dependent ATPase activity; P:retina development in camera-type eye; F:chromatin binding |
|
|
contig00389 |
upf0139 membrane protein c19orf56 homolog |
678 |
20 |
1.07E-54 |
95.80% |
1 |
C:integral to membrane |
|
|
contig00390 |
---NA--- |
313 |
0 |
|
|
0 |
|
|
|
contig00391 |
loc734098 protein |
723 |
1 |
5.73E-04 |
71.00% |
0 |
|
|
|
contig00392 |
aspartyl aminopeptidase |
1741 |
8 |
5.93E-25 |
83.25% |
7 |
C:vacuole; P:zinc ion transport; F:aspartyl aminopeptidase activity; F:metalloendopeptidase inhibitor activity; P:proteolysis; F:zinc ion binding; F:metallopeptidase activity |
EC:3.4.11.21 |
|
contig00393 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig00394 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
contig00395 |
---NA--- |
447 |
0 |
|
|
0 |
|
|
|
contig00396 |
---NA--- |
361 |
0 |
|
|
0 |
|
|
|
contig00397 |
ankyrin repeat and socs box-containing 12 |
501 |
20 |
1.62E-26 |
83.05% |
2 |
; P:ubiquitin cycle |
|
|
contig00398 |
transmembrane and coiled-coil domains 1 |
245 |
20 |
2.03E-15 |
97.65% |
3 |
C:Golgi membrane; C:integral to membrane; C:endoplasmic reticulum membrane |
|
|
contig00399 |
mediator complex subunit 26 |
271 |
20 |
1.51E-26 |
80.20% |
9 |
F:translation elongation factor activity; P:RNA elongation; P:regulation of transcription from RNA polymerase II promoter; P:transcription initiation from RNA polymerase II promoter; F:DNA binding; F:RNA polymerase II transcription mediator activity; P:transcription antitermination; ; F:transcription coactivator activity |
|
|
contig00400 |
heat shock protein 90kda member 1 |
2134 |
20 |
0 |
94.40% |
14 |
P:response to hypoxia; C:sarcoplasmic reticulum; C:cytosol; F:RNA binding; F:calcium ion binding; P:protein folding; C:extracellular space; P:anti-apoptosis; C:melanosome; F:ATP binding; C:endoplasmic reticulum lumen; F:low-density lipoprotein receptor binding; C:perinuclear region of cytoplasm; F:unfolded protein binding |
|
|
100 Rows returned.